Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my guiding principle in this crisis is simple: You cannot manage a balance sheet if you destroy your soul, and you cannot protect shareholders by killing patients. Delaying disclosure of a fatal side effect to protect a stock price is not only a profound ethical failure; it is corporate suicide.Read the full answer
The 48-Hour Plan: Disclose, Protect, Lead My Core Decision (Before Hour 1) I am disclosing. Not in six months. Not after "more data." Now. Here's why, before we get into logistics: The math that makes this non-negotiable: 1 in 8,000 across 4 million patients over 5 years means approximately 500 people are at risk of…Read the full answer